Launching an FDA-regulated connected patient monitoring device with no prior hardware security testing. Needed to pass pre-market cybersecurity review within 45 days.
Briskinfosec conducted a full hardware teardown, JTAG/UART interface analysis, firmware extraction and reverse engineering, BLE communication fuzzing, and secure boot validation.
Discovered 12 hardware-level vulnerabilities including an exposed debug interface and unencrypted BLE communications. All issues resolved before FDA submission. Device approved on first review.
“Their hardware team found vulnerabilities our software testers never would have caught. The JTAG interface finding alone could have been a recall-level issue.”